Nara; Susheel Jethanand
Patent Applications and Registrations
Patent applications and USPTO patent grants for Nara; Susheel Jethanand.The latest application filed is for "substituted amide compounds useful as farnesoid x receptor modulators".
Company Profile
13.19.29
- Nara; Susheel Jethanand - Mumbai IN
- Nara; Susheel Jethanand - Bangalore IN
- Nara; Susheel Jethanand - Chembur Mumbai
- Nara; Susheel Jethanand - Karnataka IN
Patent Activity
| Patent | Date |
|---|---|
| Substituted Amide Compounds Useful As Farnesoid X Receptor Modulators App 20220213026 - Wacker; Dean A. ; et al. | 2022-07-07 |
| Substituted Bicyclic Compounds As Farnesoid X Receptor Modulators App 20220162201 - Wacker; Dean A. ; et al. | 2022-05-26 |
| Inhibitors of indoleamine 2,3-dioxygenase and methods of their use Grant 11,337,970 - Cherney , et al. May 24, 2 | 2022-05-24 |
| Small Molecule Inhibitors Of Galectin-3 App 20220144818 - Liu; Chunjian ; et al. | 2022-05-12 |
| Substituted Bicyclic Compounds As Farnesoid X Receptor Modulators App 20220135550 - WACKER; Dean A. ; et al. | 2022-05-05 |
| Substituted Amide Compounds Useful As Farnesoid X Receptor Modulators App 20220081430 - Wacker; Dean A. ; et al. | 2022-03-17 |
| Substituted bicyclic compounds as farnesoid X receptor modulators Grant 11,254,663 - Wacker , et al. February 22, 2 | 2022-02-22 |
| Inhibitors of indoleamine 2,3-dioxygenase and methods of their use Grant 11,253,525 - Balog , et al. February 22, 2 | 2022-02-22 |
| Inhibitors Of Indoleamine 2,3-dioxygenase And Methods Of Their Use App 20210355113 - BALOG; James Aaron ; et al. | 2021-11-18 |
| Inhibitors Of Indoleamine 2,3-dioxygenase And Methods Of Their Use App 20210299126 - BALOG; James Aaron ; et al. | 2021-09-30 |
| Inhibitors Of Indoleamine 2,3-dioxygenase And Methods Of Their Use App 20210290613 - CHERNEY; Emily Charlotte ; et al. | 2021-09-23 |
| Substituted Bicyclic Compounds As Farnesoid X Receptor Modulators App 20210261535 - Wacker; Dean A. ; et al. | 2021-08-26 |
| Inhibitors of indoleamine 2,3-dioxygenase and methods of their use Grant 10,959,986 - Balog , et al. March 30, 2 | 2021-03-30 |
| Bridged bicyclic compounds as farnesoid X receptor modulators Grant 10,730,863 - Yoon , et al. | 2020-08-04 |
| Inhibitors Of Indoleamine 2,3-dioxygenase And Methods Of Their Use App 20200069646 - Balog; James Aaron ; et al. | 2020-03-05 |
| Inhibitors Of Indoleamine 2,3-dioxygenase And Methods Of Their Use App 20200069695 - Balog; James Aaron ; et al. | 2020-03-05 |
| Biaryl kinase inhibitors Grant 10,544,120 - Bronson , et al. Ja | 2020-01-28 |
| Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer Grant 10,399,932 - Balog , et al. Sep | 2019-09-03 |
| Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer Grant 10,399,933 - Balog , et al. Sep | 2019-09-03 |
| Bridged Bicyclic Compounds As Farnesoid X Receptor Modulators App 20190127358 - Yoon; David S. ; et al. | 2019-05-02 |
| Aryl lactam kinase inhibitors Grant 10,253,027 - Hartz , et al. | 2019-04-09 |
| Biaryl kinase inhibitors Grant 10,246,469 - Bronson , et al. | 2019-04-02 |
| Biaryl Kinase Inhibitors App 20190040080 - BRONSON; Joanne J. ; et al. | 2019-02-07 |
| Fused pyridines as kinase inhibitors Grant 10,174,044 - Nara , et al. J | 2019-01-08 |
| IDO inhibitors Grant 10,167,254 - Balog , et al. J | 2019-01-01 |
| Biaryl Kinase Inhibitors App 20180346440 - Bronson; Joanne J. ; et al. | 2018-12-06 |
| Heterocyclic kinase inhibitors Grant 10,035,777 - Dzierba , et al. July 31, 2 | 2018-07-31 |
| Fused Pyridines As Kinase Inhibitors App 20180141956 - Nara; Susheel Jethanand ; et al. | 2018-05-24 |
| Quinoline-based kinase inhibitors Grant 9,932,320 - Hartz , et al. April 3, 2 | 2018-04-03 |
| Inhibitors Of Indoleamine-2,3-dioxygenase For The Treatment Of Cancer App 20180079712 - Balog; James Aaron ; et al. | 2018-03-22 |
| Inhibitors Of Indoleamine-2,3-dioxygenase For The Treatment Of Cancer App 20180072660 - Balog; James Aaron ; et al. | 2018-03-15 |
| IDO inhibitors Grant 9,790,169 - Balog , et al. October 17, 2 | 2017-10-17 |
| Heterocyclic Kinase Inhibitors App 20170260145 - Dzierba; Carolyn Diane ; et al. | 2017-09-14 |
| Quinazoline-based Kinase Inhibitors App 20170239249 - HARTZ; Richard A. ; et al. | 2017-08-24 |
| Ido Inhibitors App 20170231999 - Balog; James Aaron ; et al. | 2017-08-17 |
| Aryl amide-based kinase inhibitors Grant 9,708,337 - Vrudhula , et al. July 18, 2 | 2017-07-18 |
| Aryl Lacta Kinase Inhibitors App 20160333006 - Vrudhula; Vivekananda M. ; et al. | 2016-11-17 |
| Quinoline-Based Kinase Inhibitors App 20160332985 - Hartz; Richard A. ; et al. | 2016-11-17 |
| Ido Inhibitors App 20160289171 - Balog; James Aaron ; et al. | 2016-10-06 |
| Aryl Ether-base Kinase Inhibitors App 20160222021 - Vrudhula; Vivekananda M. ; et al. | 2016-08-04 |
| Aryl Lactam Kinase Inhibitors App 20160152621 - Hartz; Richard A. ; et al. | 2016-06-02 |
| Aryl Amide-based Kinase Inhibitors App 20160016967 - Vrudhula; Vivekananda M. ; et al. | 2016-01-21 |
| Aryl ether-base kinase inhibitors Grant 8,969,564 - Vrudhula , et al. March 3, 2 | 2015-03-03 |
| Aryl lactam kinase inhibitors Grant 8,901,305 - Vrudhula , et al. December 2, 2 | 2014-12-02 |
| Aryl Ether-Base Kinase Inhibitors App 20140179725 - Vrudhula; Vivekananda M. ; et al. | 2014-06-26 |
| Aryl ether-base kinase inhibitors Grant 8,703,953 - Vrudhula , et al. April 22, 2 | 2014-04-22 |
| Aryl Lactam Kinase Inhibitors App 20140038999 - Vrudhula; Vivekananda M. ; et al. | 2014-02-06 |
| Aryl Ether-Base Kinase Inhibitors App 20130237555 - Vrudhula; Vivekananda M. ; et al. | 2013-09-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 